Non-profit Research Focus Target ALS is a non-profit foundation dedicated to fostering collaboration in the ALS research field, offering unique partnership opportunities for companies looking to support research and development initiatives.
Prominent Tech Stack Utilizing technologies such as theTradeDesk, Facebook Pixel, and Cloudflare CDN, Target ALS showcases a commitment to leveraging advanced tools and platforms, presenting opportunities for tech integrations or partnerships.
Financial Stability & Revenue Potential With a reported revenue of $0 - 10M, Target ALS demonstrates financial stability, offering potential donors or investors the chance to support a sustainable organization making an impact in the ALS field.
Key Location in New York City Situated in New York City, Target ALS benefits from a strategic location in a hub of innovation and philanthropic activity, making it an appealing partner or sponsor for local companies seeking community engagement.
Collaborative Ecosystem Being part of a network that includes complementary organizations like the ALS Society of Canada, ALS People, and Project ALS, Target ALS presents an opportunity for cross-collaboration and shared initiatives in the fight against ALS.
Target ALS uses 8 technology products and services including theTradeDesk, Facebook Pixel, Cloudflare CDN, and more. Explore Target ALS's tech stack below.
| Target ALS Email Formats | Percentage |
| First.Last@targetals.org | 50% |
| First.Last@targetals.org | 50% |
Research ServicesNew York, United States11-50 Employees
Founded in 2013 by former New York City Deputy Mayor and CEO of Sidewalk Labs, Dan Doctoroff with support from Bloomberg Philanthropies, Target ALS is a non-profit foundation focused on fostering collaboration to accelerate ALS drug discovery and development.
Company Overview
Funding & FinancialsTarget ALS's revenue is in the range of $10M
Funding & FinancialsTarget ALS's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com